4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-22-015769
CEO and CFO bought 6,774 shares at $7.38 ($49,992)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | 2022-06-02 | Purchase | +6,774 | $7.38 | $49,992 | 1,223,703 | D |
| Open-market purchases · 6,774 sh · avg $7.38 · $49,992 | |||||||
Loading xslF345X03/ownership.xml…